Dmitry Tsvetkov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dmitry Tsvetkov has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Maik Gollasch
Department of Internal Medicine and Geriatrics, University Medicine Greifswald, 17475 Greifswald, Germany
6 shared publications - Mario Kassmann
Department of Internal Medicine and Geriatrics, University Medicine Greifswald, Germany (M.K., Y.X., Q. Zhai, M.G.).
3 shared publications - Zhugang Chu
Department of Urology, Guizhou Provincial People’s Hospital, Guiyang, China (Z.C.).
3 shared publications - Bernd Nürnberg
University of Tübingen, Tübingen, Germany
2 shared publications - Lajos Markó
Experimental and Clinical Research Center, a joint cooperation between the Charité Medical Faculty and the Max-Delbrück Center (MDC) for Molecular Medicine, Berlin, Germany
2 shared publications - Sui Rong Wayne Chen
Libin Cardiovascular Institute of Alberta, Department of Physiology and Pharmacology, University of Calgary, Calgary, AB T2N 4Z6, Canada
2 shared publications
Latest Publications
- Open Access
- 28 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 9636
RyR2 Gain-of-Function Increases Ca2+ Spark and Ca2+ Wave Activity in Vascular Smooth Muscle Cells
Ca2+ sparks in vascular smooth muscle cells (VSMCs) regulate vascular function, and their dysregulation with ageing may contribute to vascular disease. These localized Ca2+ signals originate from ryanodine receptors (RyRs) and can initiate propagating Ca2+ waves that modulate vascular tone. However, it is still unclear which RyR isoform (RyR1, RyR2, or RyR3) primarily drives these Ca2+ signals in arterial VSMCs, as all three are present. The RyR2 contribution to vascular Ca2+ signaling was analyzed using Ca2+ sparks and waves in arterial VSMCs isolated from mice carrying the RyR2R4496C mutation. Intracellular Ca2+ signals were recorded using a fluorescent Ca2+ indicator in VSMCs from both young and older mice. Caffeine-evoked Ca2+ responses and contractions were measured to assess RyR-mediated SR Ca2+ release and vascular reactivity. VSMCs from young RyR2R4496C mice exhibited a significantly higher frequency of Ca2+ sparks and a greater percentage of cells displaying Ca2+ sparks and propagating Ca2+ waves compared with controls. The RyR2R4496C mutation enhanced RyR2 sensitivity to caffeine, resulting in larger increases in intracellular [Ca2+]i and arterial contractions in older mice. These findings demonstrate that RyR2 gain-of-function increases Ca2+ spark and Ca2+ wave activity in VSMCs, supporting a role for RyR2 in the regulation of local and propagating Ca2+ signals. Dysregulated RyR2 activity may therefore contribute to altered vascular Ca2+ signaling and could represent a potential mechanistic link to vascular dysfunction associated with ageing and metabolic stress.
- 28 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 9636
Open AccessRyR2 Gain-of-Function Increases Ca2+ Spark and Ca2+ Wave Activity in Vascular Smooth Muscle Cells
Ca2+ sparks in vascular smooth muscle cells (VSMCs) regulate vascular function, and their dysregulation with ageing may contribute to vascular disease. These localized Ca2+ signals originate from ryanodine receptors (RyRs) and can initiate propagating Ca2+ waves that modulate vascular tone. However, it is still unclear which RyR isoform (RyR1, RyR2, or RyR3) primarily drives these Ca2+ signals in arterial VSMCs, as all three are present. The RyR2 contribution to vascular Ca2+ signaling was analyzed using Ca2+ sparks and waves in arterial VSMCs isolated from mice carrying the RyR2R4496C mutation. Intracellular Ca2+ signals were recorded using a fluorescent Ca2+ indicator in VSMCs from both young and older mice. Caffeine-evoked Ca2+ responses and contractions were measured to assess RyR-mediated SR Ca2+ release and vascular reactivity. VSMCs from young RyR2R4496C mice exhibited a significantly higher frequency of Ca2+ sparks and a greater percentage of cells displaying Ca2+ sparks and propagating Ca2+ waves compared with controls. The RyR2R4496C mutation enhanced RyR2 sensitivity to caffeine, resulting in larger increases in intracellular [Ca2+]i and arterial contractions in older mice. These findings demonstrate that RyR2 gain-of-function increases Ca2+ spark and Ca2+ wave activity in VSMCs, supporting a role for RyR2 in the regulation of local and propagating Ca2+ signals. Dysregulated RyR2 activity may therefore contribute to altered vascular Ca2+ signaling and could represent a potential mechanistic link to vascular dysfunction associated with ageing and metabolic stress.
- Open Access
- 13 October 2026
- Published by Wiley in British Journal of Pharmacology
High‐resolution pressure myography reveals pressure‐dependent local contractile and geometric dynamics in the renal pelvis and ureter
Background and Purpose: Coordinated peristalsis between the renal pelvis and ureter is critical for effective urine transport. However, intraluminal pressure impact on upper urinary tract (UUT) contractility and pharmacologic responsiveness remains poorly understood due to absence of suitable investigative methods. Experimental Approach: This study introduces the first application of high‐resolution pressure myography to UUT, establishing a novel ex vivo platform enabling simultaneous, intraluminal pressure‐controlled local measurement of renal pelvic contraction frequency and amplitude and ureteral inner diameter, outer diameter, and wall thickness. To define contribution of specific Ca 2+ signaling pathways, we pharmacologically examined Ca v 1.2 L‐type, Ca v 3.x T‐type, and ryanodine receptor channels, as well as sarco/endoplasmic reticulum Ca 2+ ‐ATPase (SERCA) and neuronal involvement. Key Results: Elevating intraluminal pressure from 4 to 20 mmHg increased renal pelvic contraction frequency, while amplitude markedly decreased. Ureteral wall thinning was the main structural adaptation. Nifedipine reduced renal pelvic contraction amplitude and frequency and suppressed ureter peak contraction, all with reduced efficacy under high‐pressure conditions. Ni 2+ affected renal pelvic contractility only at high concentrations and had no effect on ureteral dynamics. Ryanodine did not alter measured parameters, and Na + and N‐type Ca 2+ channels were not involved. Conclusions and Implications: High‐resolution pressure myography reveals pressure‐dependent local contractile and geometric responses in UUT, including altered contraction dynamics, ureteral geometric remodeling, and specific Ca 2+ channel contributions. Ca v 1.2 channels modulate both amplitude and frequency, with wall thinning as principal acute structural adaptation. Reduced drug efficacy at high pressure highlights necessity to investigate possible pressure‐adapted therapies in obstructive uropathy.
- 13 October 2026
- Published by Wiley in British Journal of Pharmacology
Open AccessHigh‐resolution pressure myography reveals pressure‐dependent local contractile and geometric dynamics in the renal pelvis and ureter
Background and Purpose: Coordinated peristalsis between the renal pelvis and ureter is critical for effective urine transport. However, intraluminal pressure impact on upper urinary tract (UUT) contractility and pharmacologic responsiveness remains poorly understood due to absence of suitable investigative methods. Experimental Approach: This study introduces the first application of high‐resolution pressure myography to UUT, establishing a novel ex vivo platform enabling simultaneous, intraluminal pressure‐controlled local measurement of renal pelvic contraction frequency and amplitude and ureteral inner diameter, outer diameter, and wall thickness. To define contribution of specific Ca 2+ signaling pathways, we pharmacologically examined Ca v 1.2 L‐type, Ca v 3.x T‐type, and ryanodine receptor channels, as well as sarco/endoplasmic reticulum Ca 2+ ‐ATPase (SERCA) and neuronal involvement. Key Results: Elevating intraluminal pressure from 4 to 20 mmHg increased renal pelvic contraction frequency, while amplitude markedly decreased. Ureteral wall thinning was the main structural adaptation. Nifedipine reduced renal pelvic contraction amplitude and frequency and suppressed ureter peak contraction, all with reduced efficacy under high‐pressure conditions. Ni 2+ affected renal pelvic contractility only at high concentrations and had no effect on ureteral dynamics. Ryanodine did not alter measured parameters, and Na + and N‐type Ca 2+ channels were not involved. Conclusions and Implications: High‐resolution pressure myography reveals pressure‐dependent local contractile and geometric responses in UUT, including altered contraction dynamics, ureteral geometric remodeling, and specific Ca 2+ channel contributions. Ca v 1.2 channels modulate both amplitude and frequency, with wall thinning as principal acute structural adaptation. Reduced drug efficacy at high pressure highlights necessity to investigate possible pressure‐adapted therapies in obstructive uropathy.
- 1 July 2025
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 45 (7) , 1031-1040
Metabolic Regulation of Vascular Smooth Muscle Potassium Channels by Perivascular Adipose Tissue
This brief review describes recent advances in understanding metabolic control of vascular smooth muscle cells, highlighting the identification of KCNQ5 (K V 7.5 subfamily of voltage-gated K + channels) as a crucial component. KCNQ5 has been found to play a key role in enabling the convergence of input signals from the perivascular adipose tissue, which include numerous oxylipins. These findings are significant because they shed light on the mechanisms by which vascular smooth muscle cells regulate vascular tone and blood pressure. By focusing on the interaction between KCNQ5 and perivascular adipose tissue, research has uncovered a complex pathway that allows for the modulation of vascular responses through a variety of lipid-derived signaling molecules. This discovery not only provides deeper insight into the cellular processes affecting vascular function but also opens up potential new avenues for therapeutic interventions in vascular diseases. The identification of KCNQ5 as a pivotal mediator in these processes is a critical step forward in cardiovascular research, offering new perspectives on how vascular health can be maintained and how various diseases might be targeted more effectively.
- 1 July 2025
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 45 (7) , 1031-1040
Metabolic Regulation of Vascular Smooth Muscle Potassium Channels by Perivascular Adipose Tissue
This brief review describes recent advances in understanding metabolic control of vascular smooth muscle cells, highlighting the identification of KCNQ5 (K V 7.5 subfamily of voltage-gated K + channels) as a crucial component. KCNQ5 has been found to play a key role in enabling the convergence of input signals from the perivascular adipose tissue, which include numerous oxylipins. These findings are significant because they shed light on the mechanisms by which vascular smooth muscle cells regulate vascular tone and blood pressure. By focusing on the interaction between KCNQ5 and perivascular adipose tissue, research has uncovered a complex pathway that allows for the modulation of vascular responses through a variety of lipid-derived signaling molecules. This discovery not only provides deeper insight into the cellular processes affecting vascular function but also opens up potential new avenues for therapeutic interventions in vascular diseases. The identification of KCNQ5 as a pivotal mediator in these processes is a critical step forward in cardiovascular research, offering new perspectives on how vascular health can be maintained and how various diseases might be targeted more effectively.
- Open Access
- 9 December 2024
- Published by Taylor & Francis in Expert Opinion on Drug Discovery
- Vol. 20 (1) , 47-62
Advances in the design and development of chemical modulators of the voltage-gated potassium channels K V 7.4 and K V 7.5
Hypertension remains a major public health concern, with significant morbidity and mortality worldwide. Despite the availability of various antihypertensive medications, blood pressure control remains suboptimal in many individuals. During the last decades, KV7.4 and KV7.5, which were already known from the view of neuronal regulation, emerged as possible important players in the regulation of vascular tone and blood pressure. This review covers physiological functions and current advancements in the development of KV7.4 and KV7.5 channel modulators. The authors highlight the structural elements likely to be important for the future design of KV7subtype-selective modulators, underscoring their potential as an innovative hypertension treatment. Extensive research has been focused on targeting neuronal KV7.2 and KV7.3 channels, while KV7.4 and KV7.5 attracted less attention. Many of the developed compounds represent derivatives of flupirtine or retigabine, whereby subtype channel selectivity has only been demonstrated for a handful of individual compounds. Novel substances address additional sites within the binding pocket by incorporating new functional groups. A comprehensive and systematic evaluation of a compound set with significant subtype selectivity should be performed. The discovery of new highly active, less toxic, and selective compounds, therefore, remains the goal of further research in the coming years.
- 9 December 2024
- Published by Taylor & Francis in Expert Opinion on Drug Discovery
- Vol. 20 (1) , 47-62
Open AccessAdvances in the design and development of chemical modulators of the voltage-gated potassium channels K V 7.4 and K V 7.5
Hypertension remains a major public health concern, with significant morbidity and mortality worldwide. Despite the availability of various antihypertensive medications, blood pressure control remains suboptimal in many individuals. During the last decades, KV7.4 and KV7.5, which were already known from the view of neuronal regulation, emerged as possible important players in the regulation of vascular tone and blood pressure. This review covers physiological functions and current advancements in the development of KV7.4 and KV7.5 channel modulators. The authors highlight the structural elements likely to be important for the future design of KV7subtype-selective modulators, underscoring their potential as an innovative hypertension treatment. Extensive research has been focused on targeting neuronal KV7.2 and KV7.3 channels, while KV7.4 and KV7.5 attracted less attention. Many of the developed compounds represent derivatives of flupirtine or retigabine, whereby subtype channel selectivity has only been demonstrated for a handful of individual compounds. Novel substances address additional sites within the binding pocket by incorporating new functional groups. A comprehensive and systematic evaluation of a compound set with significant subtype selectivity should be performed. The discovery of new highly active, less toxic, and selective compounds, therefore, remains the goal of further research in the coming years.
- Open Access
- 30 January 2024
- Published by Elsevier in STAR Protocols
- Vol. 5 (1) , 102845
Protocol for assessing myogenic tone and perfusion pressure in isolated mouse kidneys
- 30 January 2024
- Published by Elsevier in STAR Protocols
- Vol. 5 (1) , 102845
Open AccessProtocol for assessing myogenic tone and perfusion pressure in isolated mouse kidneys
- Open Access
- 29 July 2022
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 119 (6) , 1441-1452
Quantifying the impact of gut microbiota on inflammation and hypertensive organ damage
Hypertension (HTN) can lead to heart and kidney damage. The gut microbiota has been linked to HTN, although it is difficult to estimate its significance due to the variety of other features known to influence HTN. In the present study, we used germ-free (GF) and colonized (COL) littermate mice to quantify the impact of microbial colonization on organ damage in HTN. 4-week-old male GF C57BL/6J littermates were randomized to remain GF or receive microbial colonization. HTN was induced by subcutaneous infusion with angiotensin (Ang) II (1.44 mg/kg/day) and 1% NaCl in the drinking water; sham-treated mice served as control. Renal damage was exacerbated in GF mice, whereas cardiac damage was more comparable between COL and GF, suggesting that the kidney is more sensitive to microbial influence. Multivariate analysis revealed a larger effect of HTN in GF mice. Serum metabolomics demonstrated that the colonization status influences circulating metabolites relevant to HTN. Importantly, GF mice were deficient in anti-inflammatory faecal short-chain fatty acids (SCFA). Flow cytometry showed that the microbiome has an impact on the induction of anti-hypertensive myeloid-derived suppressor cells and pro-inflammatory Th17 cells in HTN. In vitro inducibility of Th17 cells was significantly higher for cells isolated from GF than conventionally raised mice. The microbial colonization status of mice had potent effects on their phenotypic response to a hypertensive stimulus, and the kidney is a highly microbiota-susceptible target organ in HTN. The magnitude of the pathogenic response in GF mice underscores the role of the microbiome in mediating inflammation in HTN.
- 29 July 2022
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 119 (6) , 1441-1452
Open AccessQuantifying the impact of gut microbiota on inflammation and hypertensive organ damage
Hypertension (HTN) can lead to heart and kidney damage. The gut microbiota has been linked to HTN, although it is difficult to estimate its significance due to the variety of other features known to influence HTN. In the present study, we used germ-free (GF) and colonized (COL) littermate mice to quantify the impact of microbial colonization on organ damage in HTN. 4-week-old male GF C57BL/6J littermates were randomized to remain GF or receive microbial colonization. HTN was induced by subcutaneous infusion with angiotensin (Ang) II (1.44 mg/kg/day) and 1% NaCl in the drinking water; sham-treated mice served as control. Renal damage was exacerbated in GF mice, whereas cardiac damage was more comparable between COL and GF, suggesting that the kidney is more sensitive to microbial influence. Multivariate analysis revealed a larger effect of HTN in GF mice. Serum metabolomics demonstrated that the colonization status influences circulating metabolites relevant to HTN. Importantly, GF mice were deficient in anti-inflammatory faecal short-chain fatty acids (SCFA). Flow cytometry showed that the microbiome has an impact on the induction of anti-hypertensive myeloid-derived suppressor cells and pro-inflammatory Th17 cells in HTN. In vitro inducibility of Th17 cells was significantly higher for cells isolated from GF than conventionally raised mice. The microbial colonization status of mice had potent effects on their phenotypic response to a hypertensive stimulus, and the kidney is a highly microbiota-susceptible target organ in HTN. The magnitude of the pathogenic response in GF mice underscores the role of the microbiome in mediating inflammation in HTN.
- Open Access
- 20 June 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (12) , 6870
In Vivo Inhibition of TRPC6 by SH045 Attenuates Renal Fibrosis in a New Zealand Obese (NZO) Mouse Model of Metabolic Syndrome
Metabolic syndrome is a significant worldwide public health challenge and is inextricably linked to adverse renal and cardiovascular outcomes. The inhibition of the transient receptor potential cation channel subfamily C member 6 (TRPC6) has been found to ameliorate renal outcomes in the unilateral ureteral obstruction (UUO) of accelerated renal fibrosis. Therefore, the pharmacological inhibition of TPRC6 could be a promising therapeutic intervention in the progressive tubulo-interstitial fibrosis in hypertension and metabolic syndrome. In the present study, we hypothesized that the novel selective TRPC6 inhibitor SH045 (larixyl N-methylcarbamate) ameliorates UUO-accelerated renal fibrosis in a New Zealand obese (NZO) mouse model, which is a polygenic model of metabolic syndrome. The in vivo inhibition of TRPC6 by SH045 markedly decreased the mRNA expression of pro-fibrotic markers (Col1α1, Col3α1, Col4α1, Acta2, Ccn2, Fn1) and chemokines (Cxcl1, Ccl5, Ccr2) in UUO kidneys of NZO mice compared to kidneys of vehicle-treated animals. Renal expressions of intercellular adhesion molecule 1 (ICAM-1) and α-smooth muscle actin (α-SMA) were diminished in SH045- versus vehicle-treated UUO mice. Furthermore, renal inflammatory cell infiltration (F4/80+ and CD4+) and tubulointerstitial fibrosis (Sirius red and fibronectin staining) were ameliorated in SH045-treated NZO mice. We conclude that the pharmacological inhibition of TRPC6 might be a promising antifibrotic therapeutic method to treat progressive tubulo-interstitial fibrosis in hypertension and metabolic syndrome.
- 20 June 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (12) , 6870
Open AccessIn Vivo Inhibition of TRPC6 by SH045 Attenuates Renal Fibrosis in a New Zealand Obese (NZO) Mouse Model of Metabolic Syndrome
Metabolic syndrome is a significant worldwide public health challenge and is inextricably linked to adverse renal and cardiovascular outcomes. The inhibition of the transient receptor potential cation channel subfamily C member 6 (TRPC6) has been found to ameliorate renal outcomes in the unilateral ureteral obstruction (UUO) of accelerated renal fibrosis. Therefore, the pharmacological inhibition of TPRC6 could be a promising therapeutic intervention in the progressive tubulo-interstitial fibrosis in hypertension and metabolic syndrome. In the present study, we hypothesized that the novel selective TRPC6 inhibitor SH045 (larixyl N-methylcarbamate) ameliorates UUO-accelerated renal fibrosis in a New Zealand obese (NZO) mouse model, which is a polygenic model of metabolic syndrome. The in vivo inhibition of TRPC6 by SH045 markedly decreased the mRNA expression of pro-fibrotic markers (Col1α1, Col3α1, Col4α1, Acta2, Ccn2, Fn1) and chemokines (Cxcl1, Ccl5, Ccr2) in UUO kidneys of NZO mice compared to kidneys of vehicle-treated animals. Renal expressions of intercellular adhesion molecule 1 (ICAM-1) and α-smooth muscle actin (α-SMA) were diminished in SH045- versus vehicle-treated UUO mice. Furthermore, renal inflammatory cell infiltration (F4/80+ and CD4+) and tubulointerstitial fibrosis (Sirius red and fibronectin staining) were ameliorated in SH045-treated NZO mice. We conclude that the pharmacological inhibition of TRPC6 might be a promising antifibrotic therapeutic method to treat progressive tubulo-interstitial fibrosis in hypertension and metabolic syndrome.
- Open Access
- 8 May 2018
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 391 (8) , 833-846
Molecular basis for the sensitivity of TRP channels to polyunsaturated fatty acids
Transient receptor potential (TRP) channels represent a superfamily of unselective cation channels that are subdivided into seven subfamilies based on their sequence homology and differences in gating and functional properties. Little is known about the molecular mechanisms of TRP channel regulation, particularly of the “canonical” TRP (TRPC) subfamily and their activation by polyunsaturated fatty acids (PUFAs). Here, we analyzed the structure-function relationship of Drosophila fruit fly TRPC channels. The primary aim was to uncover the molecular basis of PUFA sensitivity of Drosophila TRP-like (TRPL) and TRPgamma channels. Amino acid (aa) sequence alignment of the three Drosophila TRPC channels revealed 50 aa residues highly conserved in PUFA-sensitive TRPL and TRPgamma channels but not in the PUFA-insensitive TRP channel. Substitution of respective aa in TRPL by corresponding aa of TRP identified 18 residues that are necessary for PUFA-mediated activation of TRPL. Most aa positions are located within a stretch comprising transmembrane domains S2–S4, whereas six aa positions have been assigned to the proximal cytosolic C-terminus. Interestingly, residues I465 and S471 are required for activation by 5,8,11,14-eicosatetraynoic acid (ETYA) but not 5,8,11-eicosatriynoic acid (ETI). As proof of concept, we generated a PUFA-sensitive TRP channel by exchanging the corresponding aa from TRPL to TRP. Our study demonstrates a specific aa pattern in the transmembrane domains S2–S4 and the proximal C-terminus essential for TRP channel activation by PUFAs.
- 8 May 2018
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 391 (8) , 833-846
Open AccessMolecular basis for the sensitivity of TRP channels to polyunsaturated fatty acids
Transient receptor potential (TRP) channels represent a superfamily of unselective cation channels that are subdivided into seven subfamilies based on their sequence homology and differences in gating and functional properties. Little is known about the molecular mechanisms of TRP channel regulation, particularly of the “canonical” TRP (TRPC) subfamily and their activation by polyunsaturated fatty acids (PUFAs). Here, we analyzed the structure-function relationship of Drosophila fruit fly TRPC channels. The primary aim was to uncover the molecular basis of PUFA sensitivity of Drosophila TRP-like (TRPL) and TRPgamma channels. Amino acid (aa) sequence alignment of the three Drosophila TRPC channels revealed 50 aa residues highly conserved in PUFA-sensitive TRPL and TRPgamma channels but not in the PUFA-insensitive TRP channel. Substitution of respective aa in TRPL by corresponding aa of TRP identified 18 residues that are necessary for PUFA-mediated activation of TRPL. Most aa positions are located within a stretch comprising transmembrane domains S2–S4, whereas six aa positions have been assigned to the proximal cytosolic C-terminus. Interestingly, residues I465 and S471 are required for activation by 5,8,11,14-eicosatetraynoic acid (ETYA) but not 5,8,11-eicosatriynoic acid (ETI). As proof of concept, we generated a PUFA-sensitive TRP channel by exchanging the corresponding aa from TRPL to TRP. Our study demonstrates a specific aa pattern in the transmembrane domains S2–S4 and the proximal C-terminus essential for TRP channel activation by PUFAs.